Author:
Zadeh Wendy Waldman,Escartin Antonio,Byrnes William,Tennigkeit Frank,Borghs Simon,Li Ting,Dedeken Peter,De Backer Marc
Subject
Neurology (clinical),Neurology,General Medicine
Reference23 articles.
1. Early identification of refractory epilepsy;Kwan;The New England Journal of Medicine,2000
2. UCB Pharma.Vimpat® (lacosamide tablets, injection, oral solution) [U.S. prescribing information]. Smyrna: UCB, Inc. http://www.vimpat.com/pdf/vimpat_PI.pdf. Last updated February 2015.
3. UCB Pharma. Vimpat® (lacosamide) EMA Summary of Product Characteristics http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000863/WC500050338.pdf. Last updated January 2015.
4. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures;Ben-Menachem;Epilepsia,2007
5. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial;Chung;Epilepsia,2010
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献